MAIA Biotechnology CEO Details Anticipated Clinical Milestones for Novel Cancer Immunotherapy in 2025 Letter to Shareholders ...

AI systems already work their magic in many areas of biomedical science, helping to solve protein structure, discover hidden ...

A field known as synthetic biology has become one of the most highly anticipated in science. Its outputs range from golden ...

We recently compiled a list of the 10 Stocks with Potential to Rise 1000 Percent. In this article, we are going to take a ...

“The potential risks from eating GM foods have not been fully investigated…. There is no scientific consensus on the safety ...

The allure of exceptional stock growth captures the attention of many investors, especially those who dream of hitting the jackpot with multi-bagger investments. One such company under scrutiny is ...

Immunic, Inc. to Participate in Scientific and Industry Conferences in April ...

NEW YORK, April 1, 2025 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX ), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory ...

The European Union has just taken a step towards deregulating New Genomic Techniques used for the improvement of agricultural ...

As nations continue to experience exponential population growth, the unending search for food security continues to take ...

Corporate investor briefings are normally civil affairs, but in the case of skin disorders specialist Clinuvel ...